EDBI joins investors in US$500m funding for US biotech unicorn
Add BT as a preferred sourceSingapore
EDBI, the investment arm of the Singapore Economic Development Board, has joined a group of investors in a US$500 million funding round for US biotech Moderna Therapeutics.
Other new investors include a wholly owned subsidiary of the Abu Dhabi Investment Authority (ADIA), BB Biotech AG, Julius Baer and Sequoia Capital China. Existing investors that also participated in this round include Fidelity Management & Research Company, Pictet, Viking Global Investors, ArrowMark Partners and Alexandria Venture Investments.
TRENDING NOW
CapitaLand Investment retrenches 90 Singapore staff in 2026 as part of restructuring
Wealth of Singapore’s 50 richest diverges as OCBC, Sheng Siong boom offsets tech slide
Can Bali swop beach capital for global capital without the skyscrapers?
Canada’s fight with the US has far bigger stakes than trade
